Aims: We have studied urine metabolic signature of chronic alcoholism (CA) before and after treatment with an Ayurvedic drug Tinospora cordifolia aqueous extract (TCE). Methods: Urinary metabolites of chronic alcoholics and apparently healthy subjects were profiled using HPLC-Q-TOF-MS. Discrimination models from the initial data sets were able to correctly assign the unknown samples to the CA, treated or healthy groups in validation sets with r 2 > 0.98.
INTRODUCTION
Excessive alcohol consumption is the third major cause of lifestyle-associated mortality all over the world (Reynolds et al., 2003) . Therefore, the development of new or improved medications for the treatment of alcohol-induced disorders affecting millions of people around the world is highly warranted. During the past decade, due to the development of metabolomics, some advances have been made in the identification, and application of alcohol biomarkers. However, biomarkers must have several features including validity, reliability and adequacy of temporal time window of assessment (Litten et al., 2010) . Despite advances, more research is needed to validate biomarkers, especially the new ones, in humans. Such biomarkers can be used to study effects of developed or improved drugs in human beings.
Currently limited pharmacotherapy options are available to treat alcohol-induced disorders (Zindel and Kranzler, 2014) . Alcohols cause broad spectrum of disorders as steatosis, cirrhosis, alcoholic hepatitis, fibrosis and hepatocellular cancer (Mikosch and Marksteiner, 2014) . Drugs currently in use to withdraw alcohol-induced symptoms include benzodiazepines, naltrexone, disulfiram and acamprosate. These drugs have shown mixed results in clinical trials but their side effects are difficult to overcome. Most of these drugs are not even approved by Food and Drug Administration to treat the patients with alcoholic liver diseases (Zindel and Kranzler, 2014) . A number of natural herbs have been reported to withdraw alcohol symptoms in traditional system of medicines. Kudzu is the excellent example of this, but its mechanisms of action are yet to be established (Maccioni et al., 2014) . Since alcohol induces multiple disorders, therefore, drugs known for overall health improvement should be tested to overcome these disorders and to reduce carvings. Tinospora cordifolia (Willd) Mier. (Menispermaceae), a well-known medicinal plant, is described in Ayurveda as 'nectar of life'. Its phyto-chemical constituents have been reported for anti-diabetic, anti-hyperlipidemic and immunomodulatory and neuroprotective activities (Castillo et al., 2014; Kosaraju et al., 2014; Puranik et al., 2014; Tiwari et al., 2014) . The present report describes chronic alcoholism (CA)-induced new urinary markers and the effects of T. cordifolia stem extract on these biomarkers using metabolonomic approach.
MATERIAL AND METHODS

Ethical clearance
The experimental protocols of the present study were reviewed and approved by the Human Ethical Committee (HEC) of DY Patil Ayurvedic College, Pune, India wide letter no. NRIBAS/2011/HEC/2023 dated 18-11-2011.
Apparatus
Autoanalyzer, D-280 (Sinnowa, China Republics); Agilent 6520 Accurate-Mass Q-TOF-MS.
Reagents
The standards of hippuric acid, 2-methylhippuric acid, carnitines, amino acids, indole-3-lactic acid, 5-methoxy-3-indoleacetic acid, berberine, palmatine, choline etc. were obtained from Sigma-Aldrich (St. Louis, MO, USA). Acetonitrile, water and formic acid were purchased from Fluka/Sigma-Aldrich (St. Louis, MO, USA). All solvents used in the study were of MS grades.
Study subjects
Alcoholic male volunteer (N = 26) and apparently healthy males (N = 28) of 36-40 years (mean age ± SD: 38 ± 2.0 years) were selected on the basis of age and gender from Pune, Maharashtra, India. Volunteers of middle aged drinking more than 60 ml alcohol/day from the branded whisky at least six days in a week during the past 3.0-3.5 years were selected randomly. A written consent was obtained from all these volunteers and healthy individuals, who participated in this study. All volunteers were apparently healthy and alcoholics were not on any kind of regular medication. Exclusion criteria included body mass index >30 kg/m 2 , blood pressure >160/90 mm Hg, total cholesterol >7.5 mmol/l, present or prior history of cardiovascular disease, diabetes mellitus, respiratory, gastrointestinal, hepatic, renal, endocrine, or reproductive disorders.
Drug preparation
Fresh stems of T. cordifolia were collected in summer season from garden of National Research Institute of Basic Ayurvedic Sciences, CCRAS (Department of AYUSH), Nehru Garden, Kothrud, Pune. The voucher specimens (No. 207) were kept at the medicinal plant museum of the Institute. The stems were washed with deionized water, mecerized in deionized water in 20:100 ratio (wt: vol) in septic conditions and kept thing overnight at room temperature. In the morning T. cordifolia stem extract (TCE) was filtered and 100 ml (3.0 gm when lyphilized) given to the alcoholics under the guidance of an Ayurvedic physician and as described in Ayurveda. Everyday fresh extracts were prepared from the fresh plant material and given to the patients. Degradation pattern of extracts were studied and reported from our lab (Shirolkar et al., 2013) .
Standardization of drug by UPLC-Q-TOF-MS
The chromatographic separation of random samples of TCE was performed on an Agilent 1200 Series UPLC interfaced to an Agilent 6520 Accurate-Mass Q-TOF-MS as described previously (Shirolkar et al., 2013) . To assure the mass accuracy of recorded data, standards of lidocaine (234.3 m/z) and 5, 7-isoflavone (284.3 m/z) were infused with samples along with continuous internal calibration with the use of signals at a range of m/z 121.05 to m/z 922.0098.
Selective ion monitoring
For targeted MS/MS of berberine, choline, palmatine and tetrahydropalmatine the collision energies of Q-TOF-MS were adjusted to 28, 9, 32, 32 volts respectively in separate runs. Berberine, palmatine and choline were selected for quantization by using selective ion monitoring mode and quantified by using Agilent Mass Hunter Qualitative Analysis Software (Version B 2.0.0.2). A window of 100 ppm was set for fragment identification. Standards and their corresponding metabolites in the extracts were quantified using the peak size of the fragment of the extracted ion chromatogram function.
Study design
Fifty-four volunteers (26 alcoholics and 28 normal) of 36-40 years in age (Mean ± SD; 38 ± 2.0 years) enrolled in this study were selected randomly, based on age and gender. All the volunteers were kept in the day care center in the day time and given same vegetarian diet. However, after the evening meal, they left to their home. All the volunteers were asked not to take any medicine without consultation during the study period. Serum Gamma-glutamyl transpeptidase (γ-GT) patterns were observed for 1 week and the volunteers having consistent patterns of γ-GT were included in this study. Thereafter, all the 26 alcoholic volunteers were given freshly prepared 100 ml TCE daily early in the morning with an empty stomach, for 14 days. However, usual alcohol intake (60 ml/day) was continuous during the treatment period. Fasting plasma and random urine samples were collected at day 0 (after 7 days observation) and on the 14th day after the treatment with TCE.
Hematology and blood biochemistry
Plasma glucose, triglycerides, total cholesterol, low-density lipoproteinscholesterol (LDL-C) and high-density lipoproteins-cholesterol (HDL-C), serum γ-GT, serum glutamic oxaloacetic transaminase (SGOT), serum glutamic-pyruvic transaminase (SGPT), the red blood cell volume (mean corpuscular volume: MCV) and urinary creatinine were measured using autoanalyzer, D-280 (Sinnowa, China Republics).
Sample preparation for LC−MS analysis
Random urine samples were collected in test tubes containing sodium azide. Samples (2 ml) were diluted with 5% of acetonitrile in 1:1 ratio. Lidocaine and 5, 7-isoflavone (5 ppm) were added in each sample and samples were centrifuged at 4500 × g for 30 min at 4°C. Supernatants were collected and transferred to HPLC vials and placed in autosampler interfaced Q-TOF−MS instrument for analysis. All standards were dissolved in 40% acetonitrile at a final concentration of 15 µM and used for identification of various metabolites in the samples.
Q-TOF−MS/MS
Urine samples were analyzed by HPLC coupled with Q-TOF mass spectrometry. The HPLC system consisted of Poroshell 120-SB C18 column (3 × 100 mm, 2.7 µm particle size), a model 1100 binary pump, with auto sampler (Agilent Technologies, Germany). The solvent system had (A) 0.1% formic in water and (B) 0.1% formic in acetonitrile: water (80:20). The gradient mode {%/min} for solvent B 20%/ 0; 50%/18; 90%/21; 90%/25; 20%/29; 20%/35}, with a flow rate of 0.2 ml/min was used. Q-TOF mass spectrometer was operated in positive and negative ion polarity modes and total ion chromatogram (TIC) in the range of 100-1200 m/z with acquisition rate 3 spectra s 
Quality control of the data
The quality of the data was assured by injection of blank samples and quality control samples. The chromatograms of blank samples contained only low intensity peaks; therefore, it was concluded that carryover effect did not occur. Unsupervised multivariate data analysis was carried out to investigate the relationship between QC samples and data set samples of urine. Principal component analysis (PCA) showed that the replicates were closely related. Moreover, mass shifts were corrected with the help of an external standard and mass accuracy was kept between 0.01 and 6 ppm.
Data processing and statistics
MassHunter Qualitative (Agilent technologies) was used to process the data. Profile data peaks were detected, deconvoluted, deisotoped and retention time (RT) normalized. Chromatograms were aligned using m/z tolerance 0.02 and RT tolerance of 15 s. Compound were identified using 'find compounds by molecular feature' command, where absolute height of peaks less than 5000 cps and relative height of peaks less than 2.5% were discarded. MassHunter Qualitative processed data were imported in Mass Profiler Professional (Agilent Technologies) for further analysis. Data were normalized using internal standards mixed with the samples before analysis. Data were filtered using different flags, where entities were at least in 75% of the values and frequency in any one of three conditions. Coefficient variation value was kept <25% in any 1 condition out of 3. Furthermore, significance analysis and fold change analysis were carried out using turkey HSD Post Hoc test with one-way ANOVA with Benzamini-Hochberg multiple testing correction keeping P-value cut off <0.05 and fold change ≤2.0. Finally, class prediction algorithms were applied for partial least discrimination, support vector machine, Naive Bayes, decision tree and neural network analysis and building respective prediction models. Further models were trained and used for prediction of samples.
Biomarker identification
The MS/MS spectra from Q-TOF-MS were used to identify the metabolites identified in supervised discrimination analysis. The MS/MS fragmentation patterns of interested metabolites were compared with fragmentation pattern of the standards or searching for fragments and parent ions in METLIN database (http://metlin.scripps.edu/).
Spectra from the literature were also used to confirm the identity of the biomarker.
Prediction of targets of major metabolites present in TCE
Metabolomic profile TCE was analyzed as discussed above and the targets of major compounds were analyzed using online software from http://www.swisstargetprediction.ch/.
RESULTS AND DISCUSSION
Alcoholism is one of the major problems in today's society. Alcohol affects the humans physiologically as well as psychologically. Current diagnostic methods of alcoholism are to measure the levels of γ-GT, MCV, ethylglucuronide and urinary ratio of serotonin metabolites, i.e. 5-hydroxytryptophol and 5-hydroxyindoleacetic acid in serum. Sensitivity and reliability of conventional biomarkers like γ-GT, MCV and SGOT are sometime in doubt, because of their presence in other diseases. Hence, validity of reported biomarkers, search of novel biomarkers and development of integrated approaches for diagnosis and drug development for alcoholism are urgently required. So far a very few drugs are available in the market for treatment of alcoholism and its disorders 3 . Therefore, identification and validation of novel biomarkers of CA are also essential for drug development. Drug development using target molecules is challenging and time consuming task. However, drug development from traditional medicines is easy and eco-friendly. Moreover, the drug candidates can be identified using in vitro assay systems. Tinospora cordifolia is an herb known to be beneficial in a number of disease conditions (Castillo et al., 2014; Kosaraju et al., 2014; Puranik et al., 2014; Tiwari et al., 2014) . It has been reported for neuroprotective (Kosaraju et al., 2014) and immunomodulatory properties (Castillo et al., 2014; Tiwari et al., 2014) which were found to be badly affected in CA. Therefore, urinary biomarkers of CA were analyzed and changes in the levels of these biomarkers after TCE intervention were analyzed. First, TCE was standardized and its LC-MS profiles were developed for quality control.
Characterization of TCE
By using MS/MS non-targeted analysis the peaks of different metabolites were detected in TCE. Amritosides, magnoflorine, barberine, hydroxyl-ecdysone, furanolactone diterpene, cordiofolioside A, jatrorrhizine and tembetarine were observed at different RT with respect to their m/z ratio in TCE (Fig. 1) . Most of these molecules have been reported for their neuroprotective, gastroprotective, anti-diabetic and immunomodulatory activities (Antonisamy et al., 2014; Castillo et al., 2014; Kosaraju et al., 2014; Puranik et al., 2014; Tiwari et al., 2014) . Berberine, palmatine and choline, the known biomarkers of T. cordifolia, were chosen to quantitate and to assure quality control of TCE. Maintaining the optimum separation condition as reported previously from our lab (Shirolkar et al., 2013) , standards were consecutively injected to determine intra-and inter-day accuracy. Selective ion monitoring mode in MS was used to detect the berberine, palmatine and choline at 30.08, 29.7 and 6.8 min with collision energy of 28, 32 and 9 V, respectively. The intra-and inter-day variability in RTs and peak areas of these metabolites were <4%. The peak area linearity (y, mVmin) vs. concentration (x, g/ml) curves for these compounds are investigated. The results of the regression analysis and limit of quantization (LOQ) were found to be r 2 = 0.98 to 1.0 and 0.51 to 1.2 µg/ml.
From the data, it could be seen that quite good calibration from 0.02 to 100 ppm and very low LOQ in range of 51 to 82 µg/ml could be obtained. Berberine, palmatine and choline were found to be present 0.015 ± 0.002, 8.253 ± 0.325 and 3.21 ± 0.131 µg/ml respectively in the TCE samples. Variation in the random samples was found to be quite negligible and found to be <4%. Absorption of berberine, palmatine, jatrorrhizine and tembetarine by human gut and their plasma levels were confirmed in different studies (Liu et al., 2014; Spinozzi et al., 2014; Song et al., 2014) . Berberine is reported to be useful in hyperlipidemia and diabetes whereas palmatine is reported to be useful in diabetes. In this study, synergic effects of all metabolites presented in the aqueous extract were considered and found to be very useful to treat CA-induced disorders and cravings.
Hematology and blood biochemistry γ-GT has been reported as an important biomarker for the detection of excessive alcohol consumption (Jousilahti et al., 2000) . In the present study, more than 2.0 fold increase was observed in the level of γ-GT in the chronic alcoholics, which was depleted to normal level after TCE treatment. γ-GT is considered a fairy good marker of alcoholism; however, its sensitivity and specificity has been reported between 40-60 and 80% respectively (Mihas and Tavassoli, 1992) . Hence, other biomarkers are needed to be studied along with γ-GT. Therefore, SGOT and SGPT levels in plasma were determined. The levels of plasma SGOT and SGPT were also found to be increased by 2 and 5 folds respectively, indicating the oxidative stress on liver or initial liver injury due to chronic alcohol consumption. Furthermore, MCV was measured, which is also an important biomarker of alcoholism. MCV was increased significantly (P < 0.05) in the alcoholics, in the present study. All these biomarkers confirmed the present state of alcoholics and their CA habit (Table 1) . TCE treatment to alcoholics depleted the levels of SGOT and SGPT showing their ability to reduce liver damage and stress. High doses of alcohol intake stimulate the low-density lipoprotein (LDL) and also increase the transport rate of LDL particles, due to high lipoprotein lipase activity known to regulate the HDL level (Haskell et al., 1984) . The production rate of TGL, CHL, LDL and HDL were increased significantly (P < 0.05) in the alcoholics, compared to healthy individuals. However, the intervention with TCE depleted these TGL, CHL and LDL levels, significantly (Table 1) . Berberine, a component in TCE has been reported to decrease LDL, TGL and CHL levels by stabilizing mRNA of relevant proteins (Kong et al., 2004) . TCE intervention however did not show much effect on the increased levels of HDL in alcoholics (Table 1) . Overall study of conventional biomarkers of liver injury and hyperlipidemia induced by alcoholism showed the effectiveness of TCE to reduce the levels of these biomarkers to the normal levels.
Discrimination models
The non-targeted or qualitative metabolomics provides a global view of the dynamic metabolic alterations involved in pathological processes. It is physiologically holistic, non-invasive platform and a powerful new technology that allows the assessment of global metabolic profiles in easily accessible biofluids to discover a combination of biomarkers to distinguish diseased and non-diseased status of humans. Various discrimination models can be prepared by screening of thousands of metabolites present in biofluids which contains significant and specific set of differentially expressed metabolites. These models can be used to diagnose the disease condition and takes few minutes to diagnose the samples. These models are more specific and reliable as compared to convention biomarkers being a set of biomarkers. In the present study, the molecular network in alcoholics was deciphered to identify new biomarkers and to validate previously known biomarkers for disease aggressiveness. LC-MS profiles (Fig. 2 ) of random urine samples were developed from different groups along with quality control and blank samples. From the LC-MS data supervised and unsupervised PCA was used to investigate general interrelation between groups and their urinary metabolites, including clustering and outliers among the samples. Supervised and unsupervised PCA of spot urine are presented in Fig. 3 . PCA by unsupervised method showed 26.4, 14.62 and 9.7% variations, whereas supervised PCA showed 35.74, 17.9 and 11.33% variation among the groups along with X, Y and Z axis. Alcoholics treated with TCE moved toward healthy group, which showed effect of TCE treatment towards positive side. Confidence measures of Naive Bayes, and decision tree were found to be 1, whereas other three models represent confidence from 0.87 to 0.99. PLS-DA had confidence measure above 0.91. Performance of SVM has been reported superior to PLS-DA in terms of predictive accuracy with the least number of features. SVM has been reported to give better predictive model with less number of features than PLS-DA (Mahadevan et al., 2008) . However, in the present investigation we studied and trained all the five models and common features of models were described as biomarkers and used to predict class of other samples. Prediction of unknown samples by the trained models also provided same confidence measures as of models.
Metabolites of urine
All the five models were tested against unidentified samples from healthy, alcoholics and TCE-treated alcoholics. The confidence measures were found in accordance with their regression coefficients. The high ranked common metabolites which were discriminated in healthy to alcoholic and alcoholic to TCE-treated alcoholics were further chosen for biomarker analysis which had the highest influence in the models and significant P-values (<0.01). Table 2 is showing an extended list of metabolites from the discrimination models after turkey HSD Post Hoc test with one-way ANOVA and Benzamini-Hochberg multiple testing correction. Heatmap visualization of unsupervised and supervised multivariate metabolites data showed that TCEtreated alcoholics coming near to healthy individuals group (Fig. 4A and B) as shown in PCA (Fig. 2) . The majority of metabolites detected in urine were the amino acids or their products and related to fatty acid metabolism. Ethylglucuronide, a known and standard biomarker of alcoholism was found to up-regulate by 2.128 folds and depleted after TCE treatment by −3.636 folds. Confirmation of change in ethylglucuronide levels was also verified with quality control urine sample having known concentration.
Top metabolites found to be significantly decreased or increased after alcohol consumption are given in Table 2 . Serotonin, melatonin glucuronide, glutaryl-L-carnitine, 3-(3,4-dihydroxyphenyl)lactic acid, 3,4-dihydroxybutyric acid, acetylphosphate, 5-hydroxydopamine, lysoPC(6:0), proline betaine, S-aminomethyldihydrolipoamide, 5-hydroxyindoleacetic acid, 3-methylglutarylcarnitine, L-asparagine, picolinic acid, hypoxanthine, phenylacetic acid, glutamine, riboflavin, quinaldic acid, homoarginine and chenodeoxyglycocholic acid were found to be down-regulated (>2.0 folds, P < 0.01) in alcoholics.
Whereas ethyl glucuronide, 2-hydroxyglutaric acid, phenyllactic acid, one unknown nitrogen containing metabolite of m/z 415.2011, N-acetylglycine, deoxyuridine, isovalerylsarcosine, citrulline and hexanoylglycine were observed to be up-regulated by more than 2.0 fold (P < 0.01). All these metabolites can be used as individual or cumulative biomarkers of alcoholism. Models trained having these metabolites recognized and differentiated the unknown samples of alcoholics and healthy individuals with a confidence >0.997.
Discrimination models and further analysis showed that tryptophan metabolism was significantly affected by alcoholism. In the present study, significantly decreased level of serotonin and 5-hydroxyindoleacetic acid (HIAA), breakdown products of serotonin, were observed. However, levels of 5-hydroxyindole, a breakdown product of HIAA were also found to be increased. Various studies reported the decreased levels of HIAA in the urine of alcoholics. Therefore, HIAA and 5-hydroxyindole may act as better biomarkers because of their easy detectable nature. In accordance to the observations in previous study, the urinary ratio of 5-hydroxytryptophol to HIAA was reported to be significantly increased in chronic alcoholics (Wurst et al., 2004) . However, in present study 5-hydroxytryptophol was not observed. A large body of literature reported the role of the neurotransmitter serotonin in the regulation of alcohol intake and the development of Table 2 . The common and most prominent markers altered significantly (P < 0.01) in alcoholics or after TCE treatment revealed by the all five models and further analyzed by turkey HSD Post Hoc test with one-way ANOVA and Benzamini-Hochberg multiple testing correction. The metabolites were identified using accurate-mass, retention time, MS/MS fragmentation and comparisons with authentic standards alcoholism (Blum et al., 2014) . In the present study, it was found to be most affected metabolite in the alcoholics. Additionally, levels of palmitic amides, a bioactive lipid with diverse intriguing cellular and physiological effects, were found to be decreased. Palmitic amide has been reported to have potential to reduce 5-florouracil resistance in colon cancer cells. It is an important biomarker of cancer cell resistance toward 5-flurouracil (Lee et al., 2014) . In addition to this, it has sleep-induced properties to potentiate the response of 5-HT 2 receptors to serotonin. Decreased concentration of fatty amides will decrease the response of serotonin. Along with palmitic amide, serotonin levels of urine were also found to be decreased significantly. It is in accordance to Johnson that alcoholism impaired serotonin synthesis (Johnson, 2004) . Despite this, the functional significance of serotonin needs to be fully elucidated. TCE was found to ameliorate serotonin production in a very effective way and improve neurotransmission by increasing its levels (>4.0 folds) which was possible only by modulating tryptophan metabolism.
Other metabolites of tryptophan catabolism, picolinic and quinaldic acid were also found to be significantly decreased (2.672 fold) in alcoholics. Picolinic acid is produced under inflammatory conditions and regulate leukocyte recruitment and distribution into damaged tissues. Picolinic acid is reported to effect the production of L-arginine-derived reactive nitrogen intermediates in macrophages by augmenting IFN-gamma-induced NO production (Bosco et al., 2000) . Therefore, alcohol consumption impairs the NO production which causes NO-dependent vasodilatation during alcohol consumption. Impaired NO-dependent vasodilatation is also related to deficiency of tetrahydrobiopterin (BH 4 ) (Stroes et al., 1997) . Therefore, BH 4 is another important biomarker of alcoholism. In the present study, it is found to be down-regulated by 1.172 fold. TCE treatment further down-regulate BH 4 levels by 3.36 folds which need to be explored. However, citrulline another factor that regulated NO production is found to be up-regulated in alcoholics by 3.786 folds, get depleted to −2.953 fold after treatment with TCE. Increased levels of citrulline were due to inflow of NO in synthesis of L-citrulline from arginine by NO synthase. Additionally, levels of glutamine, an alternate of arginine for production of NO, were found to be depleted in alcoholics. Heavy consumption of alcohol is reported to inhibit L-glutamine synthesis and its absorption (Basuroy et al., 2005) . Increased citrulline/arginine ratio is reported to be associated with several types of disorders including hypertension and chronic kidney disease (Benedetto et al., 2000) . Previous studies have shown that decreased NO production is associated with increased severity of liver injury in alcohol-fed rats (Nanji et al., 1995) . Arginine administration was reported to improve fatty liver, necrosis, inflammation and fibrosis conditions may be due to generation of nitric oxide. Nitric oxide also has anti-oxidant effects and behaves as a pro-oxidant (Joshi et al., 1999) . To balance nitric oxide levels, homoarginine may increase nitric oxide availability and enhance endothelial function. However, a depleted level of homoarginine in alcoholics is additional evidence of impaired NO generation. TCE treatment completely reversed the levels of homoarginine showed the great efficacy of TCE to modulate NO generation.
Chronic alcoholism significantly increased the levels of urinary acetyltyrosine, acetylglutamic acid and n-acetylglycine. Increased levels of n-acetylglycine and n-acetylglutamine in rats after doses of alcohol have been reported earlier by Loftus et al. (2010) . Elevation of acetylated amino acids in humans have been reported to be linked to renal tubular injury after antibiotic treatment (Racine et al., 2004) or a mutation in the aminoacylase I (EC3.5.1.14) gene (Gerlo et al., 2006) . Acetylation of several amino acids is supporting the previous reports suggested that alcoholism inhibits aminoacylase I. Other significantly differentiated metabolite found in human urine L-2-hydroxyglutaric, O-phosphotyrosine, S-aminomethyldihydrolipoamide (an intermediate in the glycine, serine, threonine metabolism pathway), homocysteine, acetylphosphate, 3, 4-dihydroxybutyric acid, N-hexanoylglycine, and phenyllactic acid were found to be common signature of the metabolomics in chronic alcoholics. Decreased levels of homocysteine and taurine (in un-supervised analysis) in alcoholics were noticed. Homocysteine is important for glutathione, taurine and sulfate synthesis and to respond the oxidative stress caused by alcohol and certain kinds of toxin exposure. Phenyllactic acid was also reported to be noninvasive biomarkers for alcoholism and indication of early stage liver disease (Manna et al., 2011) . TCE treatment increased the levels of homocysteine and glutathione and decreased the levels of phenyllactic acid showing its in vivo anti-oxidant capability and to restore the anti-oxidant capability.
In addition, decreased carnitines levels were observed in alcoholics as compared to healthy and TCE-treated alcoholics. Acylcarnitines are directly related to fatty acid transportation to mitochondria. Acetylcarnitine, hexonylcarnitine, pimelylcarnitine, 3-methylglutarylcarnitine and glutaryl-L-carnitine levels were observed to be decreased in alcoholics. Low levels of urinary riboflavin (−2.6 folds), which is required for normal lipid metabolism and to maintain several other metabolomic pathways, strengthen the fact. There are numerous reports which documented riboflavin deficiency in alcoholics (Heap et al., 2002; Deas et al., 2005) . PPARα, an important factor in lipid metabolism, inactivation is reported to increase hexanoylglycine (indicator of multiple Acyl-CoA dehydrogenase deficiency), isovalerylsarcosine levels and decreased chenodeoxyglycocholic acid levels, as found in this study. PPARα also effects tryptophan, corticosterone and fatty acid metabolism. It indicates that the alcoholism affects the lipid metabolism badly at several points. Low levels of carnitines also indicate sleep disorder (Gramignano et al., 2006) which is noticeable in chronic alcoholics. Levels of melatonin glucuronide were also observed to very low in alcoholics, which maintain the rhythm clock of human and can cause sleep disorders. Melatonin and N-acetylserotonin are products of serotonin catalyzed by the enzyme N-acetyl transferase. As discussed above, serotonin levels were observed to be very low in alcoholics and so that melatonin production. Alcohol consumption is reported to increase glucuronide excretion and levels in urine; therefore, decreased concentration of melatonin glucuronide is the direct evidence of decreased levels of melatonin. TCE treatment reversed the effects of alcohol consumption by increasing the levels of carnitines as well as melatonin glucuronide. Increased levels of carnitines and other markers of PPARα activation in TCE-treated alcoholics indicated that TCE activates PPARα and can be used to treat hyperlipidemic conditions.
Prediction of targets of major compounds and comparison with present study
Alcoholism induces a number of disorders including liver cirrhosis, cardiovascular and psycho-physiology problems. Most of these disorders can be predicted with the help of biomarkers which were regulated through modulated pathway. Neurotransmitters are important target as well as biomarkers of alcoholism (Devaud et al., 1997) . Alcohol is reported to increase inhibitory neurotransmission [e.g. through gamma-aminobutyric acid (GABA)], while simultaneously reducing excitatory neurotransmission (e.g. through glutamate) (Pomerleau and Rosecrans, 1989) . Acetylcholine mimics or inhibitors of acetylcholiestrase are reported to modulate dopamine release (Erickson, 1996; Barik and Wonnacott, 2009) . Six neurotransmitters dopamine, acetylcholine, 5-hydroxytrptamine, glutamine, noraderanaline and γ-aminobutyric acid are reported to regulate each other's activity and important for cravings of alcohol as well as to induce other disorders. In the current study urinary glutamine level was found to be decreased by 2.6 fold in alcoholics and recovered after treatment with TCE. In alcoholics, increased levels of GABA and decreased levels of glutamine were reported previously (Valenzuela, 1997) . At the same time several authors reported that dopamine becomes over-active during alcohol withdrawal (Sano et al., 1992; Clements et al., 1996) but not by all (Weiss et al., 1996) . Target prediction of TCE components by online software from http://www.swisstargetprediction.ch/ showed that most of the compounds interfere with acetylcholinesterase (AChE) and contribute toward inactivation of the neurotransmitter acetylcholine. Palmatine, berberine and columbamine were found to be best inhibitor of acylcholinestrase and showed <0.96 probability, whereas tinosporinone also showed <0.5 probability. All these compounds block the neurotransmission by acetylcholine. Synergic inhibition of acetylcholinestrase by berberine and palmatine was recently reported (Mak et al., 2014) . Palmatine, berberine magnoflorine has shown properties as a neuronal acetylcholine receptor agonist. Further molecular modeling studies showed that columbamine, another compound present in TCE, targets the dual active sites of AChE. Molecular modeling studies confirmed that it target both the catalytic active site and the peripheral anionic site of AChE. This is the first report where AChE inhibitory activity has been associated with columbamine as a lead molecule. Therefore, TCE inhibit acetylcholine production but magnoflorine present in it acts as agonist and produce signal, in the same way as nicotine. However, observations need to be verified in vitro or in vivo.
Two other compounds, columbine and tinosporide were predicted as competitive inhibitor of G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins (see Supplementary Table S1 ). Molecular modeling shows that these compounds bind in the same way as N-cyclopropylmethyl, a narcotic antagonist that is effective orally and has been proposed for the treatment of heroin addiction (Ray et al., 2010) . Binding of ligands causes a conformation change that triggers signaling via guanine nucleotide-binding proteins and inhibit the activity of adenylate cyclase. It inhibits release of neurotransmitter by reducing calcium ion currents and increasing potassium ion conductance.
Several other compounds were also analyzed for their predictive targets and showed various targets including receptor protein-tyrosine kinase erbB-2 for jatrorrhizine and tyrosyl-DNA phosphodiesterase 1 (Tdp1) and carbonic anhydrase for others (see Supplementary Table  S1 ). Inhibition of ErbB2 (Schroeder et al., 2014) and Tdp1 (Maha et al., 2013; Bermingham et al., 2014) have been regarded as potential therapeutics in some forms of cancer, whereas carbonic anhydrase inhibitors have been established as diuretics and in the management of mountain sickness, gastric and duodenal ulcers, neurological disorders or osteoporosis (Supuran, 2013) .
CONCLUSION
Effect of alcohol on the rat metabolomic profiles has been reported by several authors in recent years. However, this is the first time comprehensive study to explore change in human metabolome under influence of alcohol and after treatment with a well-known Ayurvedic drug Tinospora. The metabolomic data obtained in this study validated several previously reported biomarkers of alcoholism and provide new, significant mechanistic clues concerning the effects of alcohol on metabolomics. The urinary metabolomics data supported the previous observation and validated disruption of the lipid, amino acids and tryptophan/quinolinic acid/NAD pathways regulated by PPARα in alcoholics. Neurotransmission was severely affected due to decreased synthesis of serotonin as well as lack of enhancer, fatty amides. It is further supported by decreased melatonin synthesis, a neurotransmitter which required for normal rhythm of body. Increase in phenyllactic acid was correlated well with increased levels of aspartate aminotransferase (AST). Importantly, findings indicate the disrupted NO synthesis in addition to above reported pathways which is important to maintain vasodilation and anti-oxidant capacity of cells. In addition, several novel biomarkers including L-2-hydroxyglutaric acid, cystathione, 5-hydroxyindole, O-phosphotyrosine, S-aminomethyldihydrolipoamide, homocysteine, acetylphosphate, 3,4-dihydroxybutyric acid, N-hexanoylglycine, tetrahydrobiopterin, homoarginine and citrulline/arginine were identified. The SVM and PLS-DA models can be used efficiently to distinguish alcoholics and non-alcoholics and to explore the effect of drugs on the alcoholics. From the present data several metabolites could be used as novel non-invasive biomarkers of alcoholism and oxidative stress. More, importantly, TCE was found to be highly effective to reverse the impacts of alcohol by activation of PPARα, increased production of serotonin and modulation of NO production. Decreased concentration of glucuronides in the urine indicates that TCE block the alcohol metabolism. However, mechanism could not be established. Target prediction of TCE is showing the capability of TCE to modulate neurotransmission and lipid metabolism, important events in alcoholism. Therefore, TCE can be used alone or as adjunct for the treatment of alcoholism or its disorders. Furthermore, active compounds can be identified and isolated to use them as model drug candidates or drugs after proper trials.
